Clinical trial
Developing Robust Treatment Options for Mal de Débarquement Syndrome
NCT05460520 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Developing Robust Treatment Options for Mal de Débarquement Syndrome
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 1, 2023
- Completion date
- April 30, 2027
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mal de débarquement syndrome